Montesan, Mylene B.

HRN: 28-93-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2026
CEFUROXIME 1.5GM (VIAL)
05/04/2026
05/11/2026
IV
1.5G
Q8H
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: